The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

Medera has completed patient dosing in Cohort B of its ongoing MUSIC-HFpEF Phase I/IIa study of SRD-002 for heart failure ...

SUCCEED trial enables remote participation for small cell lung cancer patients, addressing location barriers and enhancing research opportunities. NXP800 shows promise in recurrent, platinum-resistant ...

The PanCAN Patient Services team is here for patients and their loved ones as they navigate clinical trials. Our Case Managers offer personal, one-to-one support at every step of the search and ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate pelacarsen to a Phase III test of Eli Lilly’s next-gen Alzheimer's drug—are poised ...

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

Household finances— not race or demographics —are the strongest predictors of participation in cancer research studies, suggests new findings that contradict long-held assumptions about why more ...

Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...

Pilot studies and feasibility trials form a critical component of the clinical research process by enabling investigators to assess the practicality of study protocols on a smaller scale prior to ...